Express Scripts Holding Co. (NASDAQ:ESRX) saw a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 26,067,130 shares, a growth of 6.0% from the August 15th total of 24,585,066 shares. Approximately 4.1% of the company’s stock are sold short. Based on an average trading volume of 4,745,667 shares, the days-to-cover ratio is currently 5.5 days.

In other news, VP Christopher A. Mcginnis sold 1,785 shares of the business’s stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $70.77, for a total transaction of $126,324.45. Following the completion of the sale, the vice president now owns 4,955 shares in the company, valued at approximately $350,665.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total transaction of $847,334.40. Following the sale, the director now owns 14,918 shares of the company’s stock, valued at approximately $1,050,227.20. The disclosure for this sale can be found here. 0.54% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of the stock. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of Express Scripts Holding by 49.9% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,646,371 shares of the company’s stock valued at $1,110,195,000 after buying an additional 4,874,043 shares during the period. BlackRock Fund Advisors boosted its position in Express Scripts Holding by 1.3% in the first quarter. BlackRock Fund Advisors now owns 9,508,996 shares of the company’s stock valued at $653,173,000 after buying an additional 121,543 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Express Scripts Holding by 7.6% in the second quarter. Massachusetts Financial Services Co. MA now owns 7,768,039 shares of the company’s stock valued at $588,818,000 after buying an additional 547,365 shares during the period. Boston Partners boosted its position in Express Scripts Holding by 16.5% in the second quarter. Boston Partners now owns 7,063,742 shares of the company’s stock valued at $535,432,000 after buying an additional 998,544 shares during the period. Finally, Ameriprise Financial Inc. boosted its position in Express Scripts Holding by 19.5% in the second quarter. Ameriprise Financial Inc. now owns 6,278,887 shares of the company’s stock valued at $475,934,000 after buying an additional 1,025,739 shares during the period. 88.48% of the stock is owned by institutional investors.

Express Scripts Holding (NASDAQ:ESRX) opened at 69.25 on Wednesday. The firm has a 50-day moving average of $73.93 and a 200 day moving average of $73.68. Express Scripts Holding has a 52 week low of $65.55 and a 52 week high of $89.20. The firm has a market capitalization of $43.64 billion, a PE ratio of 17.11 and a beta of 1.31.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Monday, July 25th. The company reported $1.57 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.57. Express Scripts Holding had a net margin of 2.64% and a return on equity of 23.98%. The company earned $25.20 billion during the quarter, compared to the consensus estimate of $25.42 billion. During the same quarter last year, the company earned $1.44 earnings per share. Express Scripts Holding’s revenue for the quarter was down .9% on a year-over-year basis. Analysts predict that Express Scripts Holding will post $6.37 earnings per share for the current year.

ESRX has been the subject of several recent analyst reports. Morgan Stanley downgraded shares of Express Scripts Holding from an “equal weight” rating to an “underweight” rating and boosted their price objective for the stock from $67.00 to $70.00 in a research report on Monday, June 20th. Cowen and Company restated a “positive” rating and set a $83.00 price objective on shares of Express Scripts Holding in a research report on Wednesday, June 15th. Zacks Investment Research downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Tuesday, July 19th. Bank of America Corp. restated a “neutral” rating and set a $82.00 price objective on shares of Express Scripts Holding in a research report on Tuesday, June 7th. Finally, Jefferies Group reduced their price objective on shares of Express Scripts Holding from $98.00 to $88.00 and set a “buy” rating for the company in a research report on Tuesday, July 26th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $82.05.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with MarketBeat.com's FREE daily email newsletter.